Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
is an important biochemical intermediate in plants and microorganisms
and inhibited both anchorage-dependent and -independent proliferation in the pancreatic cancer cell line PANC-1
Dirksen RT
InChi: InChI=1S/C27H33N5O2/c1-27(2
3)4/h4-11H
MK-3697 p-016 is an important biochemical intermediateMK 3697 is a highly potent, orally bioavailable selective orexin 2 receptor antagonists . MK 3697 is also the third insomnia drug, currently being developed by Merck. MK 3697 has Ki = 0. 95 nM. Orexin receptor antagonists have demonstrated clinical utility for the treatment of insomnia. In vivo tests results on MK 3697 demonstrated improved stability and TDI profiles as well as excellent sleep efficacy across species. Product information CAS Number: